Sherry Wang

Sherry Wang, RAC, is a seasoned regulatory affairs professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the Sr. Director of Regulatory Affairs at SpringWorks Therapeutics since May 2022, Sherry is the global regulatory lead for various projects, focusing on strategy development and execution for clinical and marketing applications in the US and EU. Prior roles include Director of Regulatory Affairs at Deciphera Pharmaceuticals and Associate Director of Regulatory Affairs at AstraZeneca, where Sherry contributed to numerous investigational drugs and marketing applications. Sherry's background also encompasses regulatory leadership in vaccine and cell therapy clinical trials at the National Institutes of Health and quality control management in earlier roles. Sherry holds a Master of Science in Regulatory Sciences from The Johns Hopkins University, a Master of Science in Pharmacology and Therapeutics from the University of Manitoba, Canada, and a Bachelor of Science in Pharmacy from China Pharmaceutical University.